John Johnson

Insider Reports History

Entity
Individual
Location
Dendreon Corporation, 1301 2 Nd Avenue, Seattle, WA
Signature
/s/ Leslie D. Funtleyder, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Johnson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Applied Therapeutics, Inc. Executive Chairman, Director Common Stock 500K $2.92M $5.83 Dec 19, 2024 Direct
Xeris Biopharma Holdings, Inc. Director Common Stock 891K $1.7M $1.91 Jun 5, 2024 Direct
Axogen, Inc. Director Common Stock 29K $223K $7.68 Sep 1, 2024 Direct
Axogen, Inc. Director Employee Stock Option (right to purchase) 18.2K $163K $8.95 Jun 6, 2024 Direct
Axogen, Inc. Director Stock Option (right to purchase) 20.4K $142K $6.95 Sep 1, 2023 Direct
Verastem, Inc. Director Common Stock 8.33K $90.6K $10.87 Jun 18, 2024 Direct
Axogen, Inc. Director Restricted Stock Units 0 $0 $7.68 Sep 1, 2024 Direct
Applied Therapeutics, Inc. Executive Chairman, Director Stock Option (Right to Buy) 1M Dec 19, 2024 Direct
Verastem, Inc. Director Stock Option (right to buy) 12.5K Jun 18, 2024 Direct
Strongbridge Biopharma plc Chief Executive Officer, Director Ordinary Shares 0 $2.06 Oct 5, 2021 Direct
Strongbridge Biopharma plc Chief Executive Officer, Director Stock Option (Right to Buy) 0 Oct 5, 2021 Direct
Xeris Biopharma Holdings, Inc. Director Stock Option (Right to Buy) 0 Mar 18, 2024 Direct

Insider Reports Filed by John Johnson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLT Applied Therapeutics, Inc. Dec 19, 2024 2 $0 4 Dec 20, 2024 Executive Chairman, Director
APLT Applied Therapeutics, Inc. Dec 19, 2024 0 $0 3 Dec 20, 2024 Executive Chairman, Director
AXGN Axogen, Inc. Sep 1, 2024 2 $0 4 Sep 4, 2024 Director
VSTM Verastem, Inc. Jun 18, 2024 2 $0 4 Jun 20, 2024 Director
AXGN Axogen, Inc. Jun 6, 2024 2 $0 4 Jun 10, 2024 Director
XERS Xeris Biopharma Holdings, Inc. Jun 5, 2024 1 $0 4 Jun 5, 2024 Director
XERS Xeris Biopharma Holdings, Inc. Mar 18, 2024 2 $429K 4 Mar 18, 2024 Director
XERS Xeris Biopharma Holdings, Inc. Mar 15, 2024 1 $0 4 Apr 1, 2024 Director
VSTM Verastem, Inc. Mar 11, 2024 5 $0 4 Mar 13, 2024 Director
AXGN Axogen, Inc. Sep 1, 2023 2 $0 4 Sep 7, 2023 Director
XERS Xeris Biopharma Holdings, Inc. Jun 7, 2023 1 $0 4 Jun 7, 2023 Director
AXGN Axogen, Inc. Jun 1, 2023 2 $0 4 Jun 5, 2023 Director
VSTM Verastem, Inc. May 15, 2023 1 $0 4 May 16, 2023 Director
VSTM Verastem, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
XERS Xeris Biopharma Holdings, Inc. Jun 8, 2022 2 $0 4 Jun 9, 2022 Director
AXGN Axogen, Inc. Jun 1, 2022 2 $0 4 Jun 3, 2022 Director
VSTM Verastem, Inc. May 12, 2022 1 $0 4/A Dec 20, 2022 Director
XERS Xeris Biopharma Holdings, Inc. Oct 5, 2021 8 $46.6K 4/A Oct 8, 2021 Director
SBBP Strongbridge Biopharma plc Oct 5, 2021 2 $0 4 Oct 6, 2021 Chief Executive Officer, Director
XERS Xeris Biopharma Holdings, Inc. Oct 5, 2021 0 $0 3 Oct 5, 2021 Director
SBBP Strongbridge Biopharma plc Oct 1, 2021 1 -$690K 4 Oct 5, 2021 Chief Executive Officer, Director
AXGN Axogen, Inc. Jul 19, 2021 1 $0 4 Jul 21, 2021 Director
AXGN Axogen, Inc. Jul 19, 2021 0 $0 3 Jul 21, 2021 Director
SBBP Strongbridge Biopharma plc Jul 2, 2021 1 -$157K 4 Jul 7, 2021 Chief Executive Officer, Director
VSTM Verastem, Inc. Jun 28, 2021 1 $0 4 Jun 30, 2021 Director